Rentokil Initial plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RKLIF research report →
Price Chart
About the company
Rentokil Initial Plc engages in the provision of business support services. The firm's products and services protect people from pest-borne disease and the risks of poor hygiene. It operates through the following geographical segments: North America, Europe, UK and Sub-Saharan Africa, Asia and MENAT, and Pacific.
- CEO
- Michael A. Duffy
- IPO
- 2005
- Employees
- 63,388
- HQ
- Crawley, WS, GB
Get TickerSpark's AI analysis on RKLIF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.92B
- P/E
- 24.17
- Fwd P/E
- 28.43
- PEG
- 0.29
- P/S
- 1.40
- P/B
- 2.07
- EV/EBITDA
- 9.14
- Div Yield
- 1.87%
- Gross Margin
- 72.11%
- Op Margin
- 12.13%
- Net Margin
- 3.92%
- ROE
- 5.82%
- ROIC
- 5.68%
Latest fiscal year · YoY change
- Revenue
- $7.05B+29.7%
- Gross Profit
- $2.31B-49.3%
- Op Income
- $964.67M
- Net Income
- $479.78M+56.3%
- EPS
- $0.19+58.3%
- OCF Growth
- +47.1%
- FCF Growth
- +69.5%
- 52W High
- $6.51
- 52W Low
- $3.92
- 50D MA
- $5.85
- 200D MA
- $5.02
- Beta
- 0.43
- RSI (14)
- 10
- Avg Volume
- 1.24K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Rentokil reported solid first-half growth and cash flow, but the new CEO said the company will simplify the business and reinvest savings to fix North America’s slower commercial growth.· July 30, 2026
- Half-year revenue rose 4.5% to $3.589 billion, organic growth was 3.6%, and adjusted EPS increased 8.3%.
- Operating profit grew 6.6% to $556 million, with margin up 30 bps to 15.5%; free cash flow conversion was 96%.
- North America revenue increased 4.2% to $2.197 billion, but residential lead flow weakened late in Q2 and commercial growth lagged.
- Management retired the 2027 North America 20% margin target, saying savings will be reinvested into growth and that more efficiency work is still ahead.
- International improved sequentially, with Q2 pest control organic growth of 5.4% and half-year international operating margin at 19.1%.
Reported half-year revenue was $3.589 billion, up 4.5%, with organic revenue growth of 3.6%. Adjusted operating profit was $556 million, up 6.6%, and adjusted operating margin was 15.5%, up 30 basis points; adjusted EPS grew 8.3%. Free cash flow conversion was 96%, leverage fell to 2.4x from 0.4x lower than a year ago, and the interim dividend was raised 8%. North America revenue rose 4.2% to $2.197 billion, with organic growth of 3.7% and operating profit of $393 million; International revenue rose 5.0% to $1.392 billion, with organic growth of 3.5% and operating profit of $266 million. For the full year, management still expects cash conversion of at least 80% and profit in line with current market expectations, while central cost growth should moderate to a low-double-digit full-year rate. They also increased cash outflow guidance for termite provision utilization to $115 million to $125 million and raised full-year one-off/adjusting items guidance to $110 million to $120 million.
Michael Duffy said his main priorities are customer focus, sales and operational excellence, and business simplification, with the goal of returning the company to market-level organic growth and better margins over time. His tone was confident but candid: he said the company has strong brands and a right to win, but also acknowledged that the business is too complex and that front-line teams need more support, tools and standardization. He emphasized that the company should not be reinvented, but should standardize and scale what already works.
Paul Edgecliffe-Johnson focused on the numbers and the cost base. He cited 4.5% revenue growth to $3.589 billion, 6.6% operating profit growth to $556 million, 15.5% margin, 96% cash conversion, and leverage of 2.4x, saying the balance sheet is back within the 2 to 2.5x target range. He also detailed transformation savings of $45 million gross in the half and $28 million net, with a gross savings run rate of around $90 million annualized, and noted $75 million lower net debt. He said the North America 20% margin target was retired because savings will be redirected into growth, not because margin improvement is off the table.
Analysts pressed management on the weaker North America residential lead flow late in Q2 and into July, the decision to retire the North America 20% margin target, and how much restructuring or portfolio simplification might follow. Management said the lead weakness was mainly softness in termite leads, with over-indexing in housing-pressured geographies, and that quick fixes already include adding lead coordinators and streamlining field sales entry. On the margin target, they said the issue is timing and reinvestment: margins should still rise, but extra fuel is being redirected into growth, especially in North America commercial and broader simplification efforts. They also said portfolio changes would be selective, with disposals considered only where a market is not a fit.
The company is still growing revenue, profit, and cash flow while improving retention and getting leverage back within target. Management believes North America residential is already improving, international pest control is accelerating, and cost savings can be redeployed into higher-growth opportunities. The new CEO is bringing a clear operating playbook and says the company has many opportunities to improve execution without reinventing the business.
North America commercial remains a weak spot, and residential lead flow softened late in the quarter and into July, especially in termite and in some housing-pressured geographies. The company also retired its 2027 North America 20% margin target, which signals that growth reinvestment may delay near-term margin expansion. Management admitted the business is too complex and that some of the turnaround work could take up to 2 years, with additional transformation costs still to come.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 98.7%
- Shares Outstanding
- 2.52B
- Float Shares
- 2.48B
Our RKLIF coverage
Recent articles, reports, and earnings notes.
No research on RKLIF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RKLIF report →Rentokil Initial (OTCMKTS:RKLIF) Shares Down 2.7% – Here’s Why
defenseworld.net · Apr 8
Rentokil Initial (OTC:RKLIF) Trading 2% Higher – Should You Buy?
defenseworld.net · Jan 14
Rentokil Initial (OTC:RKLIF) Shares Up 7.5% – Here’s What Happened
defenseworld.net · Dec 5
Rentokil Initial (OTC:RKLIF) Shares Up 3.7% – Here’s Why
defenseworld.net · Nov 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.